Summary
This study identifies glycopyrrolate, an FDA-approved small molecule, as a promoter of retinal ganglion cell (RGC) survival and axon regeneration after optic nerve injury, leading to partial restoration of visual function. These findings have potential implications for treating optic nerve damage conditions that can compromise light perception and circadian photoentrainment pathways.
Key Findings
- Lycium barbarum polysaccharides (LBP) promoted long-distance axon regeneration after severe peripheral nerve injury and optic nerve crush in adult mammals
- FDA-approved glycopyrrolate promoted RGC survival, sustained CNS axon regeneration, and increased neural firing in the superior colliculus after optic nerve crush
- Glycopyrrolate enhanced visual target re-innervation by regenerating RGC axons, resulting in partial restoration of visual function after optic nerve crush
Categories
Eye Health & Vision: Study demonstrates restoration of visual function through retinal ganglion cell survival and axon regeneration after optic nerve crush, directly relevant to retinal and optic nerve health.
Author(s)
NPB Au, G Kumar, P Asthana, F Gao
Publication Year
2022
Number of Citations
12
Related Publications
Eye Health & Vision
- Diminished pupillary light reflex at high irradiances in melanopsin-knockout mice
- Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa
- Melanopsin and rod–cone photoreceptors play different roles in mediating pupillary light responses during exposure to continuous light in humans
- Characteristic patterns of dendritic remodeling in early-stage glaucoma: evidence from genetically identified retinal ganglion cell types
- Intrinsically photosensitive melanopsin retinal ganglion cell contributions to the pupillary light reflex and circadian rhythm